Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Effector Therapeutics Enters Into Investment Agreement With Lincoln Park Capital For Up To $50 Mln

Jan 24 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS INC - ENTERS INTO INVESTMENT
AGREEMENT
WITH LINCOLN PARK CAPITAL FOR UP TO $50 MILLION
    * EFFECTOR THERAPEUTICS-SEES EXISTING CASH RESOURCES TO
ALLOW READ
OUT INITIAL RESPONSE, TOPLINE RESULTS FROM ZOTATIFIN PHASE 2A
DOSE-EXPANSION COHORTS
    * EFFECTOR THERAPEUTICS - EXPECTS EXISTING CASH RESOURCES
WILL
ALLOW READ OUT OF TOPLINE DATA FROM BOTH ACTIVE COHORTS IN 
PHASE 2B KICKSTART TRIAL

Source text for Eikon:  ID:nGNX5xpn46 
Further company coverage:  EFTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news